Total Funding
8
54
Total FundingSeed raised
Growth Score
-12 pts
Heat Score
-33 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
215940
GlyGenix Therapeutics develops therapeutic products for the treatment of cure metabolic disorders.
Ramesh Ratan: CFOPast Role: Xcellerex, CFO
About the Company
GlyGenix Therapeutics, Inc. develops therapeutic products for the treatment of cure metabolic disorders. The company manufactures and delivers genes to cure GSD1a. It has partnerships with National Institutes of Health, Duke University, University of Florida, and Royal Philips Electronics. GlyGenix Therapeutics, Inc. was founded in 2006 and is
based in Woodbridge, Connecticut.
